Brief: PhaseBio Pharmaceuticals Says Co Obligated To Buy Minimum Of About $14 Mln Of Batches Of Product From BioVectra

PhaseBio Pharmaceuticals

11/03/2021 13:23

March 11 (Reuters) - PhaseBio Pharmaceuticals Inc  PHAS.O :
    * PHASEBIO PHARMACEUTICALS - PURSUANT TO MINIMUM ANNUAL
COMMITMENTS, CO OBLIGATED TO BUY MINIMUM OF ABOUT $14 MILLION OF
BATCHES OF PRODUCT IN YEARS 2022 THROUGH 2023 FROM BIOVECTRA
    * PHASEBIO PHARMACEUTICALS - PURSUANT TO MINIMUM ANNUAL
COMMITMENTS, CO OBLIGATED TO BUY ABOUT $37 MILLION OF BATCHES OF
PRODUCT IN 2024 FROM BIOVECTRA
    * PHASEBIO PHARMACEUTICALS - PURSUANT TO MINIMUM ANNUAL
COMMITMENTS, CO OBLIGATED TO BUY ABOUT $48 MILLION OF BATCHES OF
PRODUCT IN EACH OF YEARS 2025 THROUGH 2031 FROM BIOVECTRA
    * PHASEBIO PHARMACEUTICALS - IN THE EVENT, CO DOES NOT
PURCHASE
APPLICABLE MINIMUM ANNUAL COMMITMENT, CO TO MAKE PAYMENT TO
BIOVECTRA IN AMOUNT EQUAL TO THEN-APPLICABLE SUPPLY PRICE

Source text: [https://bit.ly/3vdYjCN]
Further company coverage:  PHAS.O 

 ((Reuters.Briefs@thomsonreuters.com;))